This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An author's correction has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilson, A. D.
Right arrow Articles by Morgan, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilson, A. D.
Right arrow Articles by Morgan, A. J.

 Previous Article  |  Next Article 

Journal of Virology, May 2002, p. 5071-5081, Vol. 76, No. 10
0022-538X/02/$04.00+0     DOI: 10.1128/JVI.76.10.5071-5081.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Primary Immune Responses by Cord Blood CD4+ T Cells and NK Cells Inhibit Epstein-Barr Virus B-Cell Transformation In Vitro

A. Douglas Wilson* and Andrew J. Morgan

Department of Pathology and Microbiology, School of Medical Sciences, University of Bristol, Bristol BS8 1TD, United Kingdom

Received 9 May 2001/ Accepted 11 February 2002

Epstein-Barr virus (EBV) transformation of B cells from fetal cord blood in vitro varies depending on the individual sample. When a single preparation of EBV was simultaneously used to transform fetal cord blood samples from six different individuals, the virus transformation titer varied from less than zero to 105.9. We show that this variation in EBV transformation is associated with a marked primary immune response in cord blood samples predominately involving CD4+ T cells and CD16+ CD56+ NK cells. After virus challenge both CD4+ T cells and NK cells in fetal cord blood cultures expressed the lymphocyte activation marker CD69. The cytotoxic response against autologous EBV-infected lymphoblastoid cell line (LCL) targets correlated with the number of CD16+ CD69+ cells and was inversely correlated with the virus transformation titer. Although NK activity was detected in fresh cord blood and increased following activation by the virus, killing of autologous LCLs was detected only following activation by exposure to the virus. Both activated CD4+ T cells and CD16+ NK cells were independently able to kill autologous LCLs. Both interleukin-2 and gamma interferon were produced by CD4+ T cells after virus challenge. The titer of EBV was lower when purified B cells were used than when whole cord blood was used. Addition of monocytes restored the virus titer, while addition of resting T cells or EBV-activated CD4+ T-cell blasts reduced the virus titer. We conclude that there are primary NK-cell and Th1-type CD4+ T-cell responses to EBV in fetal cord blood that limit the expansion of EBV-infected cells and in some cases eliminate virus infection in vitro.

* Corresponding author. Mailing address: Department of Pathology and Microbiology, School of Medical Sciences, University Walk, University of Bristol, Bristol BS8 1TD, United Kingdom. Phone and fax: 44-0-117-9287891. E-mail: doug.wilson{at}bristol.ac.uk.

Journal of Virology, May 2002, p. 5071-5081, Vol. 76, No. 10
0022-538X/02/$04.00+0     DOI: 10.1128/JVI.76.10.5071-5081.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Liu, A., Claesson, H.-E., Mahshid, Y., Klein, G., Klein, E. (2008). Leukotriene B4 activates T cells that inhibit B-cell proliferation in EBV-infected cord blood-derived mononuclear cell cultures. Blood 111: 2693-2703 [Abstract] [Full Text]  
  • MacArthur, G. J., Wilson, A. D., Birchall, M. A., Morgan, A. J. (2007). Primary CD4+ T-Cell Responses Provide both Helper and Cytotoxic Functions during Epstein-Barr Virus Infection and Transformation of Fetal Cord Blood B Cells. J. Virol. 81: 4766-4775 [Abstract] [Full Text]  
  • Pappworth, I. Y., Wang, E. C., Rowe, M. (2007). The Switch from Latent to Productive Infection in Epstein-Barr Virus-Infected B Cells Is Associated with Sensitization to NK Cell Killing. J. Virol. 81: 474-482 [Abstract] [Full Text]  
  • Marodi, L. (2006). Neonatal Innate Immunity to Infectious Agents. Infect. Immun. 74: 1999-2006 [Full Text]  
  • Le Clorennec, C., Youlyouz-Marfak, I., Adriaenssens, E., Coll, J., Bornkamm, G. W., Feuillard, J. (2006). EBV latency III immortalization program sensitizes B cells to induction of CD95-mediated apoptosis via LMP1: role of NF-{kappa}B, STAT1, and p53. Blood 107: 2070-2078 [Abstract] [Full Text]  
  • Gudgeon, N. H., Taylor, G. S., Long, H. M., Haigh, T. A., Rickinson, A. B. (2005). Regression of Epstein-Barr Virus-Induced B-Cell Transformation In Vitro Involves Virus-Specific CD8+ T Cells as the Principal Effectors and a Novel CD4+ T-Cell Reactivity. J. Virol. 79: 5477-5488 [Abstract] [Full Text]  
  • Liu, A., Arbiser, J. L., Holmgren, A., Klein, G., Klein, E. (2005). PSK and Trx80 inhibit B-cell growth in EBV-infected cord blood mononuclear cells through T cells activated by the monocyte products IL-15 and IL-12. Blood 105: 1606-1613 [Abstract] [Full Text]  
  • Salek-Ardakani, S., Lyons, S. A., Arrand, J. R. (2004). Epstein-Barr Virus Promotes Human Monocyte Survival and Maturation through a Paracrine Induction of IFN-{alpha}. J. Immunol. 173: 321-331 [Abstract] [Full Text]  
  • Ferlazzo, G., Munz, C. (2004). NK Cell Compartments and Their Activation by Dendritic Cells. J. Immunol. 172: 1333-1339 [Full Text]  
  • Kang, I., Quan, T., Nolasco, H., Park, S.-H., Hong, M. S., Crouch, J., Pamer, E. G., Howe, J. G., Craft, J. (2004). Defective Control of Latent Epstein-Barr Virus Infection in Systemic Lupus Erythematosus. J. Immunol. 172: 1287-1294 [Abstract] [Full Text]  
  • Nikiforow, S., Bottomly, K., Miller, G., Munz, C. (2003). Cytolytic CD4+-T-Cell Clones Reactive to EBNA1 Inhibit Epstein-Barr Virus-Induced B-Cell Proliferation. J. Virol. 77: 12088-12104 [Abstract] [Full Text]  
  • Ruvolo, V., Navarro, L., Sample, C. E., David, M., Sung, S., Swaminathan, S. (2003). The Epstein-Barr Virus SM Protein Induces STAT1 and Interferon-Stimulated Gene Expression. J. Virol. 77: 3690-3701 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»